US and EU industry push for progress with MRA (Mutual Recognition Agreement) implementation
This article was originally published in Clinica
Executive Summary
Now that the first phase of the mutual recognition agreement (MRA) between the US and the European Union is on track to begin in the first week of December, regulators must move quickly to develop an action plan that can monitor progress and resolve problematic issues, say representatives from the medical device industry on both sides of the Atlantic.